Accenture has made a strategic investment in BehaVR, a leading innovator in VR digital wellness and digital therapeutics experiences.

Through its proprietary delivery platform for creating, validating, and operating digital therapeutics solutions, the BehaVR platform enables personalized, dynamic experiences that are governed and adapt in real-time based on biometrics, protocols, and ML models.

According to Accenture’s digital health technology vision 2022 report, healthcare leaders expect VR and the metaverse to positively impact the future of care. It is expected that more meaningful, tailored experiences will further humanize healthcare by aligning the right technology, operating model, data and culture to deliver more efficient and empathetic care.

BehaVR is now part of Accenture Ventures’ Project Spotlight, an engagement and investment program that connects emerging technology startups with the Global 2000 to fill strategic innovation gaps.

Tom Lounibos, managing director, Accenture Ventures, said: “Mental health issues in the US and around the world have never been more prevalent, and there is an urgent need for increased resources and treatment.

“BehaVR is using the immersive power of VR to activate and rewire neural pathways to treat people suffering from anxiety, stress, fear, and other conditions.”

Aaron Gani, founder and CEO of BehaVR, said: “Around the world, providers and employers are grappling with how to enhance the depth, breadth and efficacy of their mental health service offerings, and we believe VR-based digital therapeutics can play a vital role in helping them do all of those things.

“Joining Accenture Ventures’ Project Spotlight is a powerful way to drive increased awareness of BehaVR’s VR-powered mental health services as we continue our work to lower barriers and deliver advanced care to the people that so desperately need it.”